Pfizer Inc. (PFE)
Drug Manufacturers - General · Healthcare · $149.2B
Intrinsic Value (Consensus)
$20.52
Current Price
$26.04
Margin of Safety
-21.2%
21.2% Above Intrinsic Value
Value: $21
Price: $26
Valuation Model Estimates
Current Price: $26.04
DCF (Discounted Cash Flow)
$20.14
Graham Number
$21.52
Earnings Power Value
$13.20
Relative Value (P/E)
$27.20
Dividend Discount Model
Not applicable
—
Consensus Value
$20.52
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
53
Profitability
15/25
Strength
25/25
Valuation
9/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $1.36
- EPS (Forward)
- $1.39
- Book Value
- $15.14
- P/E Ratio
- 19.3
- Forward P/E
- 18.9
- PEG Ratio
- —
- ROE
- 9.0%
- Debt/Equity
- 5%
- Revenue Growth
- -44.5%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 0.29
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance